Neurotrophin system activation in pleural effusions

References

• Barbacid M. 1994. The Trk family of neurotrophin receptors. J Neuroimmunol. 25:1386–1403.
   Google Scholar
• Bertollini L, Ciotti MT, Cherubini E, Cattaneo A. 1997. Neurotrophin-3 promotes the survival of oligodendrocyte precursors in embryonic hippocampal cultures under chemically defined conditions. Brain Res. 746:19–24.
   PubMedGoogle Scholar
• Chao MV, Rajagopal R, Lee FS. 2006. Neurotrophin signalling in health and disease. Clin Sci (Lond). 110 2: 167–173.
   PubMed Web of Science ®Google Scholar
• Dagnell C, Grunewald J, Idali F, Wikén M, Kemi C, Sköld CM, Planck A, Newman LS, Eklund A, Olgart Höglund CC. 2008. Increased levels of nerve growth factor in the airways of patients with sarcoidosis. J Intern Med. 264 5: 463–471.
   PubMedGoogle Scholar
• Davidson B, Reich R, Lazarovici P, Flørenesa VA, Risberga B, Nielsenc S, Sertd B, Bedrossiane C. 2004. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma. Lung Cancer. 44:159–165.
   PubMedGoogle Scholar
• Denkins Y, Reiland J, Roy M, Sinnappah-Kang ND, Galjour J, Murry BP, Blust J, Aucoin R, Marchetti D. 2004. Brain metastases in melanoma: Roles of neurotrophins. Neuro Oncol. 6 2: 154–165.
   PubMedGoogle Scholar
• Descamps S, Leburhis X, Delehedde M, Boilly B, Hondermarck H. 1998. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J Biol Chem. 3:16659–16662.
   Google Scholar
• Fox AJ, Patel HJ, Barnes PJ, Belvisi MG. 2001. Release of nerve growth factor by human pulmonary epithelial cells: Role in airway inflammatory diseases. Eur J Pharmacol. 424:159–162.
   PubMed Web of Science ®Google Scholar
• Freund-Michel V, Frossard N. 2008. The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther. 117 1: 52–76.
   PubMed Web of Science ®Google Scholar
• Goretzki PE, Wahl RA, Becker R, Koller C, Branscheid D, Grussendorf M, Roeher HD. 1987. Nerve growth factor (NGF) sensitizes human medullary thyroid carcinoma (hMTC) cells for cytostatic therapy in vitro. Surgery. 102 6: 1035–1042.
   PubMedGoogle Scholar
• Hamanoue M, Middleton G, Wyatt S, Jaffray E, Hay RT, Davies AM. 1999. p75-Mediated NF-κB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol Cell Neurosci. 14 1: 28–40.
   PubMedGoogle Scholar
• Hoglund CO, de Blay F, Oster J-P, Duvernelle C, Kassel O, Pauli G, Frossard N. 2002. Nerve growth factor levels and localization in human asthmatic bronchi. Eur Respir J. 20:1110–1116.
   PubMedGoogle Scholar
• Islam O, Loo TX, Heese K. 2009. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res. 6 1: 42–53.
   PubMed Web of Science ®Google Scholar
• Janis LS, Steins DG. 1996. Intraseptal injections of NGF attenuates edema formation following septal lesions in the rat. Neurosci Lett. 214 1: 21–24.
   PubMedGoogle Scholar
• Kawamura K, Kawamura N, Sato W, Fukuda J, Kumagai J, Tanaka T. 2009. Brain-derived neurotrophic factor promotes implantation and subsequent placental development by stimulating trophoblast cell growth and survival. Endocrinology. 150 8: 3774–3782.
   PubMed Web of Science ®Google Scholar
• Kim JYH, Sutton ME, Lu DJ, Tracey A, Cho TA, Liliana C, Goumnerova LC, Goritchenko L, Kaufman JR, Lam KK, Billet AL, Tarbell NJ, Wu J, Allen JC, Stiles CD, Segal RA, Pomeroy SL. 1999. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res. 59:711–719.
   PubMed Web of Science ®Google Scholar
• Lei L, Parada LF. 2007. Transcriptional regulation of Trk family neurotrophin receptors. Cell Mol Life Sci. 64 5: 522–532.
   PubMed Web of Science ®Google Scholar
• Lewin GR, Barde YA. 1996. Physiology of neurotrophins. Ann Rev Neurosci. 19:289–317.
   PubMed Web of Science ®Google Scholar
• Lucas NN, Lee DW. 2009. BDNF increases BrdU-IR cells in the injured adult zebra finch hippocampus. Neuroreport. 20 12: 1066–1070.
   PubMedGoogle Scholar
• Menter DG, Herrmann JL, Nicolson GL. 1995. The role of trophic factors and autocrine/paracrine growth factors in brain metastasis. Clin Exp Metastasis. 13 2: 67–88.
   PubMedGoogle Scholar
• Missale C, Codignola A, Sigala S, Finardi A, Paez-Pereda M, Sher E, Spano P. 1998. Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines. Proc Natl Acad Sci USA. 95:5366–5371.
   PubMed Web of Science ®Google Scholar
• Nakagawara A, Brodeur GM. 1997. Role of neurotrophins and their receptors in human neuroblastomas: A primary culture study. Eur J Cancer. 33:2050–2055.
   PubMed Web of Science ®Google Scholar
• Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. 1994. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol. 14 1: 759–767.
   PubMedGoogle Scholar
• Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel E. 1995. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and human glioblastoma cell line expressing high affinity nerve growth factor binding sites involving tyrosine kinase signaling. Cancer Res. 55:2212–2219.
   PubMedGoogle Scholar
• Pahlman S, Hoehner JC. 1999. Neurotrophin receptors, tumor progression and tumor maturation. Mol Med Today. 2:432–438.
   Google Scholar
• Perez-Pinera P, Hernandez T, García-Suárez O, de Carlos F, Germana A, Del Valle M, Astudillo A, Vega JA. 2007. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas. Mol Cell Biochem. 295 1–2: 19–26.
   PubMedGoogle Scholar
• Ricci A, Greco S, Mariotta S, Felici L, Bronzetti E, Cavazzana A, Cardillo G, Amenta F, Bisetti A, Barbolini G. 2001. Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol. 25:439–446.
   PubMedGoogle Scholar
• Ricci A, Graziano P, Bronzetti E, Saltini C, Sciacchitano S, Cherubini E, Renzoni E, Du Bois RM, Grutters JC, Mariotta S. 2007. Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis. 24 1: 13–23.
   PubMedGoogle Scholar
• Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL. 1994. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA. 91 26: 12867–12871.
   PubMedGoogle Scholar
• Sortino MA, Condorelli F, Vancheri C, Chiarenza P, Bernardini R, Consoli U, Canonico PL. 2000. Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: Role of the high- and low-affinity NGF receptors. Mol Endocrinol. 14:124–136.
   PubMedGoogle Scholar
• Underwood CK, Coulson EL. 2008. The p75 neurotrophin receptor. Int J Biochem Cell Biol. 40 9: 1664–1668.
   PubMedGoogle Scholar
• van Staveren WCG, Weiss Solís DY, Hébrant A, Detours V, Dumont JE, Maenhaut C. 2009. Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?. Biochem Biophys Acta. 1795:92–103.
   PubMed Web of Science ®Google Scholar
• Zhu ZW, Friess H, Wang L, Di Mola FF, Zimmermann A, Buchler MW. 2000. Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer. Anticancer Res. 20:125–132.
   PubMedGoogle Scholar